Risk of suicide attempt associated with isotretinoin: a nationwide cohort and nested case-time-control study
Author(s) -
C. Droitcourt,
Emmanuel Nowak,
C. Rault,
André Happe,
Béranger Le Nautout,
Sandrine Kerbrat,
Frédéric Balusson,
F. Poizeau,
D. Travers,
Jean-Marc Sapori,
Emmanuel Lagarde,
Grégoire Rey,
B. Guillot,
Emmanuel Oger,
A. Dupuy
Publication year - 2019
Publication title -
international journal of epidemiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.406
H-Index - 208
eISSN - 1464-3685
pISSN - 0300-5771
DOI - 10.1093/ije/dyz093
Subject(s) - isotretinoin , medicine , interquartile range , nested case control study , incidence (geometry) , cohort study , population , cohort , confidence interval , poison control , pediatrics , acne , demography , emergency medicine , environmental health , dermatology , physics , sociology , optics
Isotretinoin is the only effective treatment for severe acne. An isotretinoin-related suicide risk is still debated and under scrutiny by regulatory agencies. Our objectives were: to assess the risk of suicide attempt before, during and after isotretinoin treatment; to detect any potential triggering effect of isotretinoin initiation on suicide attempt.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom